Literature DB >> 8088085

Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome.

S Rantapää-Dahlqvist, T K Nilsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088085     DOI: 10.1007/bf02249038

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  16 in total

1.  Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens.

Authors:  A D Blann; A C Wainwright; P Emery
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  von Willebrand factor is an acute phase reactant in man.

Authors:  B E Pottinger; R C Read; E M Paleolog; P G Higgins; J D Pearson
Journal:  Thromb Res       Date:  1989-02-15       Impact factor: 3.944

3.  The association between cutaneous vasculitis and decreased blood fibrinolytic activity.

Authors:  W J Cunliffe; I S Menon
Journal:  Br J Dermatol       Date:  1971-02       Impact factor: 9.302

4.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

6.  Enzyme immunoassay for factor VIII-related antigen.

Authors:  J Cejka
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

7.  Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases.

Authors:  E Nylander Lundqvist; O Back; T K Nilsson; S Rantapaa-Dahlqvist
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

8.  Decreased fibrinolytic activity in juvenile chronic arthritis.

Authors:  L Mussoni; G Pintucci; G Romano; F De Benedetti; M Massa; A Martini
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

9.  Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.

Authors:  J M Jordan; N B Allen; S V Pizzo
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

10.  Alterations in C1 inhibitor and clotting factor concentrations in primary biliary cirrhosis and other chronic liver diseases.

Authors:  A Danielsson; T K Nilsson; P Uddenfeldt
Journal:  Scand J Gastroenterol       Date:  1990-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.